Loading...
Found 685 results for in-health
A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY)
M
Marc Rovner
The purpose of this study is to compare the effect of tezepelumab with placebo on moderate or severe COPD exacerbations in participants with moderate to very severe COPD. THIS STUDY IS ENROLLING BY INVITATION ONLY
Evaluation of genetic mutations in African American with glaucoma associated with long anterior zonules (LAZ)
W
Weiming Mao
What is the purpose of this study?Long anterior zonules (LAZ) is the presence of the zonular fibers (a tissue that holds the lens in place) attaching to the anterior part of the lens. LAZ is a rare disease and is genetically associated with certain gene mutations. It has been reported …
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Efficacy of Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) in Patients with Idiopathic Pulmonary Fibrosis
R
Ryan Boente
This Phase 2, randomized, double-blind, placebo-controlled, multi-center study will compare the safety, tolerability, and efficacy of inhaled LTI-03 to placebo in participants diagnosed with IPF within 5 years of Screening who may be receiving standard of care (SoC) antifibrotic therapy.LTI-03 is an experimental medication breathed into the lungs using an …
Ep0239 Sleep Disturbances, Behavior, Activities Of Daily Living, And Caregiver Burden Among Patients Diagnosed With Dravet Syndrome And Lennox-Gastaut Syndrome Initiating Treatment With Fenfluramine (Fintepla): A Prospective Multicenter Study
J
Jason Santiago
Fenfluramine (Fintepla®) is currently approved in your country for the treatment of seizures associated with Dravet syndrome (DS) and for Lennox-Gastaut syndrome (LGS). In addition to seizures, almost all patients experience multiple and significant non-seizure disorders. This study aims to describe the treatment-related impact of fenfluramine on non-seizure outcomes, ie, …
An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or Abl-Class Philadelphia Chromosome-Like B-Cell Acute Lymphoblastic Leukemia
S
Sandeep Batra, MD
This phase III trial compares the effect of the combination of blinatumomab with dasatinib or imatinib and standard chemotherapy versus dasatinib or imatinib and standard chemotherapy for treating patients with Philadelphia chromosome positive (PH+) or ABL-class Philadelphia chromosome-like (Ph-Like) B-Cell acute lymphoblastic leukemia (B-ALL). Blinatumomab is a bispecific antibody that …
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
A
Anna Elizabeth Thomas
The purpose of this study is to determine if an investigational drug can prevent Bronchopulmonary Dysplasia, reducing the burden of chronic lung disease in extremely premature infants, as compared to extremely premature infants receiving standard neonatal care alone.THIS STUDY IS ENROLLING BY INVITATION ONLY
Inhaled Nitric Oxide (Ino) for Congenital Diaphragmatic Hernia (Cdh) - The "Nono Trial" - a Multi-Center, De-Implementation, Stepped-Wedge, Cluster-Randomized Trial Within an Established Collaborative
B
Brian Gray, MD
The purpose of this study is to Determine if deimplementation of iNO in the post-natal resuscitation/stabilization phase affects the composite outcome of ECLS use and/or mortality, as well as ECLS use, mortality, and/or oxygenation in CDH newborns and to establish the cost-effectiveness of deimplementing iNO as a therapy in the …
A Randomised, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension to Assess the Pharmacokinetics, Safety, and Efficacy of Empagliflozin Tablets in Paediatric Patients with Chronic Kidney Disease (Empa-Kidney Kids)
M
Myda Khalid
This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD. Other goals of the study are to find out how empagliflozin is tolerated and handled …
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
S
Sandeep Batra, MD
This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come back (relapsed). Down syndrome patients with relapsed B-ALL are included in this study. Blinatumomab is an antibody, which is a protein …
A Phase 2A Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderate to Severe Crohn's Disease
M
Monika Fischer, MD
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and weight loss. Treatments are available but do not work the same for all patients or may …
Please choose between Voice or SMS based delivery of verification code
or